Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Dyberg

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neuro-Oncology Advances|December 11, 2024
Genomic tumor evolution dictates human medulloblastoma progressionYana Ruchiy, Ioanna Tsea, Efthalia Preka, et al.
Journal of Neuro-Oncology|March 31, 2015
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomasEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Rho-associated kinase is a therapeutic target in neuroblastomaCecilia Dyberg, Susanne Fransson, Teodora Andonova, et al.
Scientific Reports|April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluationEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Nature Communications|March 23, 2022
GIT1 protects against breast cancer growth through negative regulation of NotchSongbai Zhang, Ayako Miyakawa, Malin Wickström, et al.
Nature Communications|January 5, 2020
Integrative discovery of treatments for high-risk neuroblastomaElin Almstedt, Ramy Elgendy, Neda Hekmati, et al.
JCI Insight|August 9, 2022
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastomaThale Kristin Olsen, Cecilia Dyberg, Bethel Tesfai Embaie, et al.
Cancer Research Communications|March 6, 2023
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent MannerAlina Castell, Qinzi Yan, Karin Fawkner, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neuro-Oncology Advances|December 11, 2024
Genomic tumor evolution dictates human medulloblastoma progressionYana Ruchiy, Ioanna Tsea, Efthalia Preka, et al.
Journal of Neuro-Oncology|March 31, 2015
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomasEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Rho-associated kinase is a therapeutic target in neuroblastomaCecilia Dyberg, Susanne Fransson, Teodora Andonova, et al.
Scientific Reports|April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluationEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Nature Communications|March 23, 2022
GIT1 protects against breast cancer growth through negative regulation of NotchSongbai Zhang, Ayako Miyakawa, Malin Wickström, et al.
Nature Communications|January 5, 2020
Integrative discovery of treatments for high-risk neuroblastomaElin Almstedt, Ramy Elgendy, Neda Hekmati, et al.
JCI Insight|August 9, 2022
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastomaThale Kristin Olsen, Cecilia Dyberg, Bethel Tesfai Embaie, et al.
Cancer Research Communications|March 6, 2023
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent MannerAlina Castell, Qinzi Yan, Karin Fawkner, et al.
Pageof 2